[Articles] Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial

Related Posts

• [Comment] Adjuvant chemotherapy in nasopharyngeal carcinoma

  The value of adjuvant chemotherapy after definitive radiotherapy in locoregionally advanced nasopharyngeal carcinoma has been…

• [Articles] Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial

  Adjuvant carboplatin and paclitaxel chemotherapy given after standard cisplatin-based chemoradiotherapy for unselected locally advanced cervical…

• Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy

  Background In patients with stage III melanoma, despite surgical resection and adjuvant systemic therapy, locoregional…